Item request has been placed!

Item request cannot be made.

Processing Request

نتائج البحث

Display Settings

النتائج لكل صفحة: 10

Sort By: Relevance

Filter

فلترة النتائج

Publication : british journal of cancer فلترة بواسطة : موضوع

إعادة تعيين خيارات الفبترة

Item request has been placed!

Item request cannot be made.

Processing Request

Academic Journal

Phase II study of gemcitabine and bexarotene (GEMBEX) in the treatment of cutaneous T-cell lymphoma.

Authors : Illidge, T¹; Chan, C¹; Counsell, N²

Source: British Journal of Cancer. 11/12/2013, Vol. 109 Issue 10, p2566-2573. 8p.

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

A novel inhibitor of the PI3K/Akt pathway based on the structure of inositol 1,3,4,5,6-pentakisphosphate.

Authors : Falasca, M.¹ ; Chiozzotto, D.¹; Godage, H. Y.²

Source: British Journal of Cancer. 1/4/2010, Vol. 102 Issue 1, p104-114. 11p. 1 Chart, 5 Graphs.

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

Enhancing fraction measured using dynamic contrast-enhanced MRI predicts disease-free survival in patients with carcinoma of the cervix.

Authors : Donaldson, S. B.^1,2 ; Buckley, D. L.^2,3; O'Connor, J. P.^2,4

Source: British Journal of Cancer. 1/4/2010, Vol. 102 Issue 1, p23-26. 4p. 1 Black and White Photograph, 2 Charts, 1 Graph.

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

Vascular-targeted photodynamic therapy with BF2-chelated Tetraaryl-Azadipyrromethene agents: a multi-modality molecular imaging approach to therapeutic assessment.

Authors : Byrne, A. T.^1,2; O'Connor, A. E.¹; Hall, M.³

Source: British Journal of Cancer. 11/3/2009, Vol. 101 Issue 9, p1565-1573. 9p. 1 Black and White Photograph, 1 Chart, 4 Graphs.

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

Clinician and cancer patient views on patient participation in treatment decision-making: a quantitative and qualitative exploration.

Authors : Pieterse, A. H.¹ ; Baas-Thijssen, M. C. M.¹; Marijnen, C. A. M.^2,3

Source: British Journal of Cancer. 9/16/2008, Vol. 99 Issue 6, p875-882. 8p. 2 Charts, 1 Graph.

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

Promoter hypermethylation of FANCF and outcome in advanced ovarian cancer.

Authors : Lim, S. L.¹; Smith, P.²; Syed, N.²

Source: British Journal of Cancer. 4/7/2008, Vol. 98 Issue 8, p1452-1456. 5p. 1 Diagram, 2 Charts, 1 Graph.

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

Proteomic analysis of stage I primary lung adenocarcinoma aimed at individualisation of postoperative therapy.

Authors : Maeda, J.¹; Hirano, T.¹ ; Ogiwara, A.^2,3

Source: British Journal of Cancer. 2/5/2008, Vol. 98 Issue 3, p596-603. 8p. 1 Color Photograph, 4 Charts, 3 Graphs.

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

Quality of life and quality-adjusted survival (Q-TWiST) in patients receiving dose-intensive or standard dose chemotherapy for high-risk primary breast cancer.

Authors : Bernhard, J.^1,2 ; Zahrieh, D.³; Zhang, J. J.⁴

Source: British Journal of Cancer. 1/1/2008, Vol. 98 Issue 1, p25-33. 9p. 1 Diagram, 8 Charts, 3 Graphs.

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

The therapeutic potential of a series of orally bioavailable anti-angiogenic microtubule disruptors as therapy for hormone-independent prostate and breast cancers.

Authors : Newman, S. P.¹ ; Foster, P. A.¹; Ho, Y. T.¹

Source: British Journal of Cancer. 12/17/2007, Vol. 97 Issue 12, p1673-1682. 10p. 1 Diagram, 1 Chart, 5 Graphs.

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

Combinatorial experimental protocols for Erbicin-derived immunoagents and Herceptin.

Authors : De Lorenzo, C.¹; Troise, F.¹; Cafaro, V.¹

Source: British Journal of Cancer. 11/19/2007, Vol. 97 Issue 10, p1354-1360. 7p. 1 Color Photograph, 5 Graphs.

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

نتائج البحث

فلترة النتائج

Phase II study of gemcitabine and bexarotene (GEMBEX) in the treatment of cutaneous T-cell lymphoma.

A novel inhibitor of the PI3K/Akt pathway based on the structure of inositol 1,3,4,5,6-pentakisphosphate.

Enhancing fraction measured using dynamic contrast-enhanced MRI predicts disease-free survival in patients with carcinoma of the cervix.

Vascular-targeted photodynamic therapy with BF2-chelated Tetraaryl-Azadipyrromethene agents: a multi-modality molecular imaging approach to therapeutic assessment.

Clinician and cancer patient views on patient participation in treatment decision-making: a quantitative and qualitative exploration.

Promoter hypermethylation of FANCF and outcome in advanced ovarian cancer.

Proteomic analysis of stage I primary lung adenocarcinoma aimed at individualisation of postoperative therapy.

Quality of life and quality-adjusted survival (Q-TWiST) in patients receiving dose-intensive or standard dose chemotherapy for high-risk primary breast cancer.

The therapeutic potential of a series of orally bioavailable anti-angiogenic microtubule disruptors as therapy for hormone-independent prostate and breast cancers.

Combinatorial experimental protocols for Erbicin-derived immunoagents and Herceptin.

اتصل بنا

اتبع